Recently, an important partner delegation from the Middle East visited Wixbio to check out the company’s R&D center and production base. The visit was all about getting a deeper look at Wixbio’s R&D strength, production capacity, and quality management system in biovaccine technology. Wixbio’s international business, R&D, and production teams hosted them the whole time.
At the R&D center, the delegation took a close look at Wixbio’s independently developed vaccine platform technologies, core process innovations, and quality testing systems. The R&D team walked them through the full process—from antigen design and process development to efficacy verification—highlighting the company’s solid technical foundation and ongoing innovation in vaccine R&D. The Middle Eastern clients really appreciated Wixbio’s professional R&D capabilities and innovative strength.
Afterwards, the group headed into the production base and checked out the modern production workshops that meet international GMP standards. They focused on the full vaccine production process, how the automated equipment runs, and the strict quality control steps. They were very impressed with Wixbio’s efficient production support and solid quality control system.
After the tour, both sides sat down for a talk. The Middle Eastern partners said the visit gave them a much clearer picture of Wixbio’s technical strength, production level, and quality assurance, and they wanted to take the partnership further. The two sides had a friendly chat about future product cooperation, technical support, and market expansion.
This successful visit further strengthened the mutual trust between the two sides and set the stage for even closer strategic cooperation ahead. Wixbio will keep focusing on innovation and putting quality first, working hand in hand with partners around the world to push biovaccine technology forward.
Wixbio
We’re focused on innovation in biovaccines and biopharmaceuticals. Looking forward to connecting with more international partners!
